Vancomycin (cas 1404-90-6)-induced Kounis Syndrome
-
Add time:09/01/2019 Source:sciencedirect.com
Kounis Syndrome is a rare allergic reaction that results in coronary vasospasm and may occur in patients with and without coronary artery disease. A 57-year-old man receiving pre-operative vancomycin for osteomyelitis and gangrene of the foot experienced an episode of anginal symptoms associated with transient ischemic 12-lead electrocardiogram (ECG) changes. The patient's symptoms and ECG changes abated with discontinuation of vancomycin and subsequent coronary angiography revealed no evidence of coronary artery disease. Treatment of Kounis Syndrome begins with cessation of the causative agent. Consensus guidelines for the management of Kounis Syndrome have not been established but treatment should both dilate the coronary vessels and suppress the allergic response. Coronary vasospasm after administration of antibiotics, including vancomycin, is a rare but serious reaction. It is important that Emergency Physicians recognize Kounis Syndrome as an uncommon yet dramatic and consequential reaction to such a commonly-administered antibiotic.
We also recommend Trading Suppliers and Manufacturers of Vancomycin (cas 1404-90-6). Pls Click Website Link as below: cas 1404-90-6 suppliers
Prev:ArticlesA Routine Method for the In Vitro Assay of TYROTHRICIN (cas 1404-88-2)
Next:ReviewVancomycin (cas 1404-90-6)-soaked wrapping of harvested hamstring tendons during anterior cruciate ligament reconstruction. A review of the ‘Vancomycin (cas 1404-90-6) wrap’☆☆☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Population pharmacokinetics of Vancomycin (cas 1404-90-6) in Chinese patients with augmented renal clearance09/10/2019
- Review ArticleSelection pressures of Vancomycin (cas 1404-90-6) powder use in spine surgery: a meta-analysis09/09/2019
- ReviewThe dosing and monitoring of Vancomycin (cas 1404-90-6): what is the best way forward?09/08/2019
- Short reportVancomycin (cas 1404-90-6) use in surrounding patients during critical illness and risk for persistent colonization with Vancomycin (cas 1404-90-6)-resistant Enterococcus09/07/2019
- Vancomycin (cas 1404-90-6) release from biodegradable βTCP-FeAg nanocomposites09/06/2019
- Original articleVancomycin (cas 1404-90-6)-associated drug-induced hypersensitivity syndrome09/05/2019
- A rapid and simple UPLC method for serum Vancomycin (cas 1404-90-6) determination in pediatric patients undergoing continuous infusion or intermittent infusion of Vancomycin (cas 1404-90-6)09/04/2019
- Original articleLinezolid versus Vancomycin (cas 1404-90-6) cost in the treatment of staphylococcal pneumoniaCoût du linézolide versus Vancomycin (cas 1404-90-6)e dans le traitement des pneumopathies à staphylocoque09/03/2019
- ReviewVancomycin (cas 1404-90-6)-soaked wrapping of harvested hamstring tendons during anterior cruciate ligament reconstruction. A review of the ‘Vancomycin (cas 1404-90-6) wrap’☆☆☆09/02/2019


